News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
734,365 Results
Type
Article (44824)
Company Profile (295)
Press Release (689232)
Multimedia
Podcasts (90)
Webinars (20)
Section
Business (206133)
Career Advice (2049)
Deals (35700)
Drug Delivery (124)
Drug Development (82079)
Employer Resources (174)
FDA (16579)
Job Trends (15065)
News (348903)
Policy (33009)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2668)
Accelerated approval (44)
Adcomms (28)
Allergies (161)
Alliances (50068)
ALS (196)
Alzheimer's disease (1748)
Antibody-drug conjugate (ADC) (368)
Approvals (16876)
Artificial intelligence (600)
Autoimmune disease (222)
Automation (50)
Bankruptcy (365)
Best Places to Work (11727)
BIOSECURE Act (21)
Biosimilars (201)
Biotechnology (201)
Bladder cancer (178)
Brain cancer (66)
Breast cancer (688)
Cancer (5334)
Cardiovascular disease (445)
Career advice (1732)
Career pathing (39)
CAR-T (302)
CDC (54)
Celiac Disease (2)
Cell therapy (812)
Cervical cancer (41)
Clinical research (70627)
Collaboration (1909)
Company closure (5)
Compensation (1281)
Complete response letters (73)
COVID-19 (2763)
CRISPR (102)
C-suite (988)
Cystic fibrosis (150)
Data (7074)
Decentralized trials (3)
Denatured (27)
Depression (153)
Dermatology (57)
Diabetes (550)
Diagnostics (6898)
Digital health (52)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (296)
Drug pricing (196)
Drug shortages (29)
Duchenne muscular dystrophy (270)
Earnings (91358)
Editorial (60)
Employer branding (21)
Employer resources (153)
Events (119335)
Executive appointments (1037)
FDA (20003)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (30)
Funding (1626)
Gene editing (224)
Generative AI (53)
Gene therapy (682)
GLP-1 (1023)
Government (4732)
Grass and pollen (7)
Guidances (396)
Healthcare (19048)
HIV (75)
Huntington's disease (54)
IgA nephropathy (91)
Immunology and inflammation (273)
Immuno-oncology (80)
Indications (157)
Infectious disease (3076)
Inflammatory bowel disease (203)
Inflation Reduction Act (14)
Influenza (128)
Intellectual property (273)
Interviews (322)
IPO (16714)
IRA (50)
Job creations (3670)
Job search strategy (1444)
JPM (60)
Kidney cancer (18)
Labor market (92)
Layoffs (563)
Leadership (34)
Legal (8008)
Liver cancer (100)
Longevity (28)
Lung cancer (717)
Lymphoma (407)
Machine learning (52)
Management (59)
Manufacturing (918)
MASH (177)
Medical device (13870)
Medtech (13947)
Mergers & acquisitions (20139)
Metabolic disorders (1414)
mRNA (185)
Multiple sclerosis (172)
NASH (17)
Neurodegenerative disease (384)
Neuropsychiatric disorders (98)
Neuroscience (3147)
Neurotech (1)
NextGen: Class of 2026 (6597)
Non-profit (4595)
Now hiring (73)
Obesity (666)
Opinion (283)
Ovarian cancer (185)
Pain (229)
Pancreatic cancer (256)
Parkinson's disease (338)
Partnered (33)
Patents (554)
Patient recruitment (589)
Peanut (60)
People (59684)
Pharmaceutical (59)
Pharmacy benefit managers (32)
Phase 1 (22076)
Phase 2 (31078)
Phase 3 (23135)
Pipeline (7112)
Policy (305)
Postmarket research (2585)
Preclinical (9406)
Press Release (67)
Prostate cancer (275)
Psychedelics (50)
Radiopharmaceuticals (303)
Rare diseases (1037)
Real estate (6000)
Recruiting (70)
Regulatory (25171)
Reports (54)
Research institute (2508)
Resumes & cover letters (358)
Rett syndrome (32)
RNA editing (18)
RSV (85)
Schizophrenia (164)
Series A (271)
Series B (202)
Service/supplier (12)
Sickle cell disease (111)
Special edition (23)
Spinal muscular atrophy (175)
Sponsored (45)
Startups (3679)
State (2)
Stomach cancer (18)
Supply chain (117)
Tariffs (86)
The Weekly (60)
Vaccines (1069)
Venture capital (101)
Weight loss (424)
Women's health (109)
Worklife (19)
Date
Today (55)
Last 7 days (641)
Last 30 days (2680)
Last 365 days (30130)
2026 (8033)
2025 (30381)
2024 (35482)
2023 (40327)
2022 (51536)
2021 (56046)
2020 (54405)
2019 (46880)
2018 (35319)
2017 (32458)
2016 (31930)
2015 (37930)
2014 (31655)
2013 (26843)
2012 (29023)
2011 (29673)
2010 (27747)
Location
Africa (764)
Alabama (90)
Alaska (7)
Arizona (332)
Arkansas (13)
Asia (39968)
Australia (6575)
California (12320)
Canada (3511)
China (1229)
Colorado (523)
Connecticut (528)
Delaware (366)
Europe (86872)
Florida (1849)
Georgia (393)
Hawaii (3)
Idaho (62)
Illinois (956)
India (80)
Indiana (561)
Iowa (23)
Japan (486)
Kansas (129)
Kentucky (45)
Louisiana (38)
Maine (73)
Maryland (1491)
Massachusetts (8829)
Michigan (347)
Minnesota (675)
Mississippi (6)
Missouri (138)
Montana (33)
Nebraska (29)
Nevada (135)
New Hampshire (83)
New Jersey (3273)
New Mexico (29)
New York (3245)
North Carolina (1569)
North Dakota (9)
Northern California (6093)
Ohio (367)
Oklahoma (22)
Oregon (41)
Pennsylvania (2496)
Puerto Rico (26)
Rhode Island (50)
South America (1133)
South Carolina (76)
South Dakota (1)
Southern California (4831)
Tennessee (199)
Texas (1928)
United States (43638)
Utah (367)
Vermont (1)
Virginia (291)
Washington D.C. (80)
Washington State (1006)
West Virginia (4)
Wisconsin (119)
Wyoming (2)
734,365 Results for "myriad genetics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Myriad Genetics Receives FDA Approval of the MyChoice CDx Test as the Companion Diagnostic for Zejula (niraparib) for Patients with Ovarian Cancer
March 18, 2026
·
6 min read
Press Releases
Myriad Genetics to Release Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026
February 16, 2026
·
1 min read
Press Releases
Myriad Genetics to Present at 44th Annual J.P. Morgan Healthcare Conference
January 6, 2026
·
1 min read
Press Releases
Myriad Genetics Reports Fourth Quarter and Full-Year 2025 Financial Results; Reiterates 2026 Financial Guidance Reflecting Strengthened Execution
February 24, 2026
·
31 min read
Press Releases
Myriad Genetics to Highlight Genetic Testing Advancements at 2025 National Society of Genetic Counselors Annual Conference
November 7, 2025
·
3 min read
Press Releases
Six presented abstracts at ASCO-GU 2026 reinforce the clinical impact of Myriad’s Precise MRD, Prolaris, and MyRisk tests
February 24, 2026
·
6 min read
Press Releases
Clairity, Myriad Genetics, and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast Health
November 26, 2025
·
5 min read
Press Releases
Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences - November 11, 2025
November 11, 2025
·
1 min read
Press Releases
Myriad Genetics Announces Select Preliminary Fourth Quarter and Full Year 2025 Financial Results and Introduces Full Year 2026 Financial Guidance
January 13, 2026
·
9 min read
Press Releases
Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy
September 24, 2025
·
6 min read
1 of 73,437
Next
